110 related articles for article (PubMed ID: 3697999)
1. In vitro hemopoiesis of marrow cells from myelodysplastic patients: effects of mitogen-stimulated spleen cell-conditioned medium and vitamin A and D derivatives.
Fabian I; Riklis I; Tatarsky I; Nagler A
Cancer Res; 1986 May; 46(5):2596-9. PubMed ID: 3697999
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
Nagler A; Rikilis I; Tatarsky I; Fabian I
J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
[TBL] [Abstract][Full Text] [Related]
3. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the generation of mast cells from multipotential colony-forming cells.
Li CL; Johnson GR
J Cell Physiol; 1984 Oct; 121(1):167-73. PubMed ID: 6480710
[TBL] [Abstract][Full Text] [Related]
5. Colony formation in agar by adult bone marrow multipotential hemopoietic cells.
Johnson GR
J Cell Physiol; 1980 Jun; 103(3):371-83. PubMed ID: 7400223
[TBL] [Abstract][Full Text] [Related]
6. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium.
Taetle R; Caviles A; Koziol J
Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965
[TBL] [Abstract][Full Text] [Related]
7. Effect of spleen cell conditioned medium on megakaryocytopoiesis in a short-term bone marrow culture system.
Petursson SR; Chervenick PA
J Lab Clin Med; 1988 Jan; 111(1):110-7. PubMed ID: 3335820
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of colony-stimulating-factor--dependent clonal growth of murine macrophage progenitors and their phagocytic activity by retinoic acid.
Goldman R
J Cell Physiol; 1985 May; 123(2):288-96. PubMed ID: 3872306
[TBL] [Abstract][Full Text] [Related]
9. Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.
Ohmori M; Ohmori S; Ueda Y; Yoshida Y; Okuma M
Int J Cell Cloning; 1991 Sep; 9(5):521-30. PubMed ID: 1955740
[TBL] [Abstract][Full Text] [Related]
10. Permissive role of interleukin 3 (IL-3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture.
Suda T; Suda J; Ogawa M; Ihle JN
J Cell Physiol; 1985 Aug; 124(2):182-90. PubMed ID: 3930522
[TBL] [Abstract][Full Text] [Related]
11. Effect of a new retinoidal benzoic acid derivative on normal human hematopoietic progenitor cell growth in vitro.
Fabian I; Shvartzmayer S
Cancer Res; 1986 May; 46(5):2413-5. PubMed ID: 3697984
[TBL] [Abstract][Full Text] [Related]
12. Basophil production.
Denburg JA; Davison M; Bienenstock J
J Clin Invest; 1980 Feb; 65(2):390-9. PubMed ID: 6965379
[TBL] [Abstract][Full Text] [Related]
13. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
14. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and maturation of human leukemic cells in liquid culture: activity of human placenta conditioned medium and retinoic acid.
Champelovier P; Seigneurin D
Exp Hematol; 1985 Nov; 13(10):1094-100. PubMed ID: 3863756
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
17. Functional disturbances in hemopoietic microenvironment in various forms of myelodysplastic syndrome.
Manakova T; Gerasimova L; Tsvetaeva N; Momotyuk K
Bull Exp Biol Med; 2000 Sep; 130(9):832-4. PubMed ID: 11177256
[TBL] [Abstract][Full Text] [Related]
18. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
Gidáli J; Fehér I; Hollán SR
Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
[TBL] [Abstract][Full Text] [Related]
19. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
[TBL] [Abstract][Full Text] [Related]
20. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells.
Metcalf D; Nicola NA
J Cell Physiol; 1983 Aug; 116(2):198-206. PubMed ID: 6602806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
